Benefits of three-month continuous glucose monitoring for persons with diabetes using insulin pumps and sensors

Biomedical Papers

Volumn 153, Issue 1, 2009, Pages 47-52

  Peterson, Karolina ^a   Zapletalova, Jana ^a   Kudlova, Pavla ^a   Matuskova, Veronika ^a   Bartek, Josef ^a   Novotny, Dalibor ^b   Chlup, Rudolf ^a,b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Continuous glucose monitoring; Diabetes education; Diabetes mellitus; Glucometer; Haemoglobin A1c; Insulin; Insulin pump

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD; DIABETES MELLITUS; FEMALE; GENETIC PROCEDURES; GLUCOSE BLOOD LEVEL; HUMAN; INSTRUMENTATION; INSULIN INFUSION; MALE; MIDDLE AGED;

ADULT; AGED; BIOSENSING TECHNIQUES; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; MONITORING, AMBULATORY;

EID: 70149119660     PISSN: 12138118     EISSN: 12138118     Source Type: Journal    
DOI: 10.5507/bp.2009.008     Document Type: Article

References (45)

1. Kudlová P, Chlup R. Self-monitoring u osob s diabetem. Interní Med 2006; 8(12): 539-544.
2. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002; 25: 593-598.
3. Allen BT, DeLong ER, Feussner JR. Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing. Diabetes Care 1990; 13: 1044-1050.
4. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005; 118: 422-425.
5. Davis WA, Bruce DG, Davis TM. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care 2006; 29: 1764-1770.
6. Farmer A, Wade A, Goyder E, Yudkin P, French D, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007; 335: 132-139.
7. Fontbonne A, Billault B, Acosta M, Percheron C, Varenne P, et al. Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabetes Metab 1989; 15: 255-260.
8. Garg SK. Glucose Monitoring: An important Tool for Improving Glucose Control and Reducing Hypoglycemia. Diab Technol Therap 2008; 10 (1):1-4.
9. Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003; 29: 587-594.
10. Heinemann L, Koschinsky T. Clinical Application and Challenges of Blood Glucose Measurement Technology for Self-Monitoring. Diab Technol Therap 2008; 10 (1): 27-34.
11. Nielsen JK, Gravholt CH, Djurhuus CHB, Brandt D, Becker J, Heinemann L, Christiansen JS. Continuous subcutaneous glucose monitoring shows a close correlation between mean glucose and time spent in hyperglycemia and hemoglobin A1c. J Diab Sci Tech 2007; 1(6):857-963.
12. Schwedes U, Siebolds M, Mertes G. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in noninsulin-treated type 2 diabetic patients. Diabetes Care 2002; 25: 1928-1932.
13. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005; 28: 1510-1517.
14. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006; 49: 271-278.
15. Owens DR, Barnett AH, Pickup JC, Kerr D, Bushby P, et al. Blood glucose monitoring in type 1 and type 2 diabetes: reaching a multidisciplinary consensus. Diabetes and Primary Care 2004; 6: 8-16.
16. Schiffrin A, Belmonte M. Multiple daily selfglucose monitoring: its essential role in long term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections. Diabetes Care 1981; 4: 595-600.
17. DCCT Research Group. Diabetes control and complications trial (DCCT): Results of feasibility study. Diabetes Care 1987; 10: 1-19.
18. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
19. Hirsch IB, Amstrong D, Bergenstal RM, Buckingham B, Childs BP, Clarke WL, Peters A, Wolpert H. Clinical Application of Emerging Sensor Technologies in Diabetes Management: Concensus Guidelines for Continuous Glucose Monitoring (CGM). Diab Technol Therap 2008; 10(4): 232-246.
20. Mlčák P, Fialová J, Trnková K, Chlup R. A continuous glucose monitoring system (CGMS) - A promising approach for improving metabolic control in person with type 1 diabetes mellitus treated by insulin pumps. Biomed Pap Med Fac Univ Palacký Olomouc Czech Rep 2004; 148: 33-38.
21. Chlup R, Jelenová D, Chlupová K, Zapletalová J, Chlupová L, Bartek J. Function and accuracy of glucose sensors beyond their stated expiry date. Diab Technol Therap 2006; 8(4): 495-504.
22. Chlup R, Peterson K, Zapletalová J, Langová K, Kudlová P, Přibylová H, Matušková V. Relation between HbA1c and Average One-Month Interstitial Fluid Glucose Concentration (ISFG) Determined by Continuous Glucose Monitoring - Preliminary Results of an Ongoing Study. Diabetes 2007; 56 (Suppl 1):A 527 (Abstract 2083-PO).
23. Jeha GS, Karaviti LP, Anderson B, Smith FO, Donaldson S, McGirk TS, Haymond MW. Insulin pump therapy in preschool children with type 1 diabetes mellitus improved glycemic control and decreases glucose excursion and the risk of hypoglycemia. Diab Technol Ther 2005; 7: 876-884.
24. Deiss D, Bolinder J, Riveline JP, Battelino T, Bost E, Tubianarufi N, Kerr D, Phillip M. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diab Care 2006; 29 (12): 2730-2732.
25. Chlup R, Zapletalová J, Sečkař P, Chlupová L, Táncosová S, Řezníčková M. Benefits of insulin aspart vs phosphate-buffered human regular insulin in persons with type 1 diabetes treated by means of an insulin pump. Biomed Papers 2004; 148(1): 27-32.
26. Melku V, Renard E, Lassmann-Vague V, Boivin S, Guerci B, Hanaire-Broutin H, Bringer J, Belicar P, Jeandidier N, Meyer L, Blin P, Augendre-Ferrante B, Tauber JP. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care 1998; 21: 977-982.
27. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin ChG, Wolpert HA, Buckingham BA. Sensor-Augmented Insulin Pump Therapy: Results of the First Randomized Treat-to-Target Study. Diab Technol Therap 2008; 10(5): 377-383.
28. Chlupová K, Kohnert KD, Heinke P, Augstein P, Chlup R, Salzsieder E. Resultate kontinuerlicher Glukosemessungen (CGMS) unter ambulanten Bedingungen zur Beurteilung der Stoffwechseleinstellung bei T2DM. Diabetologie und Stoffwechsel 2006; 1 (1): 94(Abstract).
29. Klonoff DC. The benefits of implanted glucose sensors. J Diab Sci Tech 2007; 1(6): 797-800.
30. Lee SW., Sweeney T, Clausen D, Kolbach C, Haasen A, Firek A, Brinegar Ch, Petrofsky J. Combined insulin pump therapy with real-time continuous glucose monitoring significantly improves glycemic control compared to multiple daily injection therapy in pump naïve patients with type 1 diabetes; Single center pilot study experience. J Diab Sci Tech 2007; 1(3):400-404.
31. Peterson K, Chlup R, Langová K, Zapletealová J, Kudlová P, Přibylová H. Benefits of continuous glucose monitoring transmitted to Paradigm 722. Diabetes 2007; 56 (Suppl 1):A531 (Abstract 2099-PO).
32. Langová K, Přibylová H, Kajabová M, Luza J. Assessment of haemoglobin A1c evolution using various statistical methods (survival analysis and linear regression) in persons with diabetes mellitus. Biomed Pap Med Fac Univ Palacký Olomouc Czech Rep. 2008; 152 (2): submitted.
33. Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 2006; 295: 1707-1708.
34. Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diab Complic 2005; 19: 178-181.
35. Home PD. Special Article - For Debate. HbA1c: the case for using estimated average glucose (eAG). Diab Med 2008; 25: 895-898.
36. Garg SK, Bookout TR, McFann KK, Kelly WC, Beatson Ch, Ellis SL, Gutin RS, Gottlieb PA. Improved Glycemic Control in Intensively Treated Adult Subjects with Type 1 Diabetes Using Insulin Guidance Software. Diab Technol Therap 2008; 10 (5): 369-375.
37. Mazze R. The Future of Self-Monitored Blood Glucose: Mean Blood Glucose versus Glycosylated Heboglobin. Diab Technol Therap 2008; 10(1): 93-101.
38. Clarke WL, Kovatchev B. Continuous glucose sensors: continuing questions about clinical accuracy. J Diab Sci Tech 2007; 1(3): 669-675.
39. Mastrototaro J, Shin J, Marcus A, Sulur G. The Accuracy and Efficacy of Real-Time Continuous Glucose Monitoring Sensor in Patients with Type 1 Diabetes. Diab Technol Therap 2008; 10 (5): 385-390.
40. Mastrototaro J, Soundararajan G, Cooper K, Shah R. Accuracy of Real-Tima Continuous Glucose Monitoring in the MiniMed Paradigm System. Diabetes 2007; 56(Suppl1): A 112 (P422).
41. Jadviščoková T, Fajkusová Z, Pallayová M, Luža J, Kuzmina G. Occurence of adverse events due to continuous glucose monitoring. Biomed Pap Med Fac Univ Palacký Olomouc Czech Rep. 2007; 151 (2): 263-266.
42. Skyler JA. CGM - a technology in evolution. Diab Technol Therap 2009;11(2):63-64.
43. Lippaiova N, Pallayova M, Kuzmina G, Peterson K, Fajkosova L, Luza J. Safety of new algorithms for premeal insulin boluses in high glycemic index meals in persons with type 1 diabetes mellitus using insulin pumps. Biomed Pap Med Fac Univ Palacky Olomouc Czech Rep. 2008; 152 (1): 73-78.
44. Pribylova H, Pallayova M, Hucikova J, Luza J. Evaluation of the new software program DegifXL4 in the determination of the glycemic indices of foodstuffs. Biomed Pap Med Fac Univ Palacky Olomouc Czech Rep. 2008; 152 (1): 65-72.
45. Fajkusová Z, Jadviscoková T, Pallayová M, Matušková V, Luža J, Kuzmina G. Glycaemic index of selected foodstuffs in healthy persons. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007, 151(2):257-261.